Letters to the Editor

A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients

Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany;
Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;
Department of Pathology, Careggi University Hospital, University of Firenze, Firenze, Italy;
Department of Pathology, Careggi University Hospital, University of Firenze, Firenze, Italy;
Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;
Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;
Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany;
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany;
DSHNHL Studiensekretariat, Universitätsklinikum des Saarlandes, Homburg, Germany;
DSHNHL Studiensekretariat, Universitätsklinikum des Saarlandes, Homburg, Germany;
Department of Hematology and Oncology, Georg-August Universität, Göttingen, Germany;
Göttingen Comprehensive Cancer Center, University Medicine Göttingen, Germany;
Department of Medicine A, University Hospital Münster, Münster, Germany;
Institute of Pathology, Universitat Würzburg, Comprehensive Cancer Center Mainfranken, Germany;
Institute of Hematology "L. and A. Seràgnoli", S. Orsola - Malpighi Hospital, Bologna, Italy;
Hammersmith Hospital and Imperial College, London, UK;
Pathodiagnostik Berlin, Berlin, Germany
Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany;
Department of Medical Biotechnology, Section of Pathology, University of Siena, Siena, Italy;
Haematologica Early view Feb 13, 2020 https://doi.org/10.3324/haematol.2019.235556